NASDAQ:HSDT Solana Q4 2024 Earnings Results & Report $2.39 +0.01 (+0.42%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$2.45 +0.06 (+2.51%) As of 10/9/2026 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Solana missed analyst earnings expectations but beat on revenue in its Q4 2024 results, released March 25, 2025. The company reported EPS of -$772.50 versus the -$705.00 consensus estimate, while revenue of $0.15 million topped the $0.10 million estimate by $0.05 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2024Report DateMarch 25, 2025TimeBefore Market OpensConference Call DateMarch 24, 2025Conference Call7:00 PM ET Solana EPS ResultsActual EPS-$772.50Consensus EPS -$705.00Beat/MissMissed by -$67.50One Year Ago EPSN/AEPS Beat Rate3 of last 5 quartersSolana Revenue ResultsActual Revenue$0.15 millionExpected Revenue$0.10 millionBeat/MissBeat by +$50.00 thousandYoY Revenue GrowthN/AUpcoming EarningsSolana's Q3 2026 earnings is estimated for Tuesday, November 17, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Solana Q4 2024 Earnings FAQ Did Solana beat earnings estimates for Q4 2024? Solana (NASDAQ:HSDT) reported earnings of -$772.50 per share for Q4 2024, missing the consensus estimate of -$705.00. The report was announced on Tuesday, March 25, 2025. What was Solana's revenue for Q4 2024? Solana reported revenue of $0.15 million for Q4 2024, against a consensus estimate of $0.10 million. When is Solana's next earnings date? Solana's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Solana on the company's earnings history page. Solana Earnings HeadlinesChina vs. crypto isn’t over yet: Solana company CEO says Beijing is studying the technology 'very closely' — 'They know that's not the technology they can ignore'October 7 at 9:29 AM | msn.comChina vs. Crypto Isn’t Over Yet: Solana CEO Says Beijing Is Studying the Technology ‘Very Closely’ — 'They Know That's Not the Technology They Can Ignore'October 7 at 6:10 AM | benzinga.comWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.October 10 at 1:00 AM | Stansberry Research (Ad)Comparing PayPal (NASDAQ:PYPL) & Solana (NASDAQ:HSDT)October 6, 2026 | americanbankingnews.comSolana Co.’s Joseph Chee Tells the Wall Street Journal: China Will Find a Way to Manage Crypto. What Happens If China Reopens?October 4, 2026 | 247wallst.comHead to Head Review: Solana (NASDAQ:HSDT) vs. Voya Financial (NYSE:VOYA)October 2, 2026 | americanbankingnews.comSee More Solana Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Solana? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solana and other key companies, straight to your email. Email Address About SolanaHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.View Solana ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
